Video Series: Current Topics in the Treatment of Advanced PCa

Targeted Agents

Philip Kantoff, MD, Andrew Armstrong, MD, William Oh, MD, and A. Oliver Sartor, MD, discuss advances in treatment of castration-resistant prostate cancer and metastatic castration-resistant prostate cancer, specifically newer hormonal therapies.

Latest Prostate Cancer Features

Latest Prostate Cancer News

Localized PCa Patients Misperceive Their Odds of Survival

Localized PCa Patients Misperceive Their Odds of Survival

Most patients have unrealistic survival expectations, which may compromise their ability to make informed treatment decisions.

Local Therapy Benefits Some Metastatic PCa Patients

Local Therapy Benefits Some Metastatic PCa Patients

Patients with a relatively low tumor risk and good general health status appear to experience the best survival.

Prostate, Bladder Cancer Linked to BPH

Prostate, Bladder Cancer Linked to BPH

In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.

Prognostic Cancer Screening Tools Show Promise

Prognostic Cancer Screening Tools Show Promise

High rates of screening for individuals with limited long-term life expectancy for all tools.

BRCA Gene Mutations May Influence Prostate Cancer Risk

BRCA Gene Mutations May Influence Prostate Cancer Risk

Multiple studies suggest they might.

Aminosalicylates Cut PCa Risk in Men with IBD

Aminosalicylates Cut PCa Risk in Men with IBD

Researchers found an adjusted 68% decreased risk of prostate cancer in men with IBD who used aminosalicylate.

PPIs Linked With Higher Rate of Post-RP Complications

PPIs Linked With Higher Rate of Post-RP Complications

Prostate cancer patients taking proton pump inhibitors also had pathologically higher stage disease.

Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk

Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk

The higher the baseline PSA levels, the greater the risk of being diagnosed with any or significant prostate cancer.

Salvage Radical Prostatectomy Offers Good Long-Term Outcomes

Salvage Radical Prostatectomy Offers Good Long-Term Outcomes

Minimally invasive surgery is associated with a lower incidence of bladder neck contracture.

Long-Term RP Outcomes Better for cT1a Prostate Cancer

Long-Term RP Outcomes Better for cT1a Prostate Cancer

Study documents superior recurrence- and metastasis-free survival compared with cT1b tumors.

Higher Radiation Dose Key to Better Brachytherapy Outcomes

Higher Radiation Dose Key to Better Brachytherapy Outcomes

A biologic effective dose less than 170 Gy2 is associated with a 2-fold increase risk dying from prostate cancer versus higher doses.

Erectile Function Recovery Better With Delayed Radiotherapy After RP

Erectile Function Recovery Better With Delayed Radiotherapy After RP

The chances of erectile function recovery improved when patients received radiation treatment more than 16 months after surgery.

Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs

Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs

In a study, use of the medication was associated with a significant 61% decreased risk.

Prostate Cancer Risk Not Increased With Testosterone Therapy

Prostate Cancer Risk Not Increased With Testosterone Therapy

In fact, some data suggest treatment may reduce prostate cancer incidence and aggressiveness.

Bladder Cancer Risk Higher Following Prostate Radiotherapy

Bladder Cancer Risk Higher Following Prostate Radiotherapy

The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.

Prostate Cancer Videos

Sign up for free e-Newsletters